Center for Financing, Access, and Cost Trends (CFACT): Publications by Staff

John F. Moeller

Authors: Miller GE, Moeller J, Stafford R
Title: New cardiovascular drugs: Patterns of use and association with non-drug health expenditures
Publication: Inquiry 42(4):397-412
Date: Winter 2005/2006
Abstract: Available on PubMed®

Authors: Moeller J, Miller GE, Banthin J
Title: Looking inside the nation's medicine cabinet: Trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001
Publication: Health Affairs 23(5):217-25
Date: Sep-Oct 2004
Abstract: Available on PubMed®

Authors: Stagnitti M, Miller GE, Moeller J
Title: Outpatient prescription drug expenses, 1999
Publication: MEPS Chartbook No. 12. AHRQ Pub. No. 04-0001. Available on the MEPS Web site
Date: 2003
Abstract: This chartbook presents data from the 1999 MEPS on spending for outpatient prescription medicines for the U.S. civilian noninstitutionalized population. This chartbook is organized into three sections. Section 1 presents a summary of overall outpatient prescription medicine expenses and payments. Section 2 contains outpatient prescription medicine expenses and payments by various population groups. Section 3 contains expenses on outpatient prescription drugs by therapeutic class.

Authors: Moeller J, Cohen S, Mathioiwetz N, Wun L
Title: Regression-based sampling for persons with high health expenditures: Evaluating accuracy and yield with the 1997 MEPS.
Publication: Med Care 41(7 Suppl):III-44-52. AHRQ Pub. No. 03-R059.
Date: July 2003
Abstract: Available on PubMed®

Authors: Wun L, Cohen S, Moeller J
Title: Refining the prediction models of low income status and future medical expenditures in the Medical Expenditure Panel Survey
Publication: American Statistical Association, Proceedings of the Section on Survey Research Methods, pp. 3813-18 (CD-ROM), Alexandria, VA
Date: 2002

Authors: Moeller J, Cohen S, Hock E, et al
Title: Projecting NMES Data: A Framework for MEPS Projections
Publication: MEPS Methodology Report No. 13. AHRQ Pub. No. 02-0009. Available on the MEPS Web site
Date: 2002
Abstract: This report describes the procedures used to project data from the 1987 NMES household survey to future years. This survey, sponsored by the National Center for Health Services Research, AHRQ's predecessor agency, provided extensive information on health expenditures by or on behalf of American families and individuals, the financing of these expenditures, and use of services. NMES data have been "aged" based on more recent household population estimates from government sources and data from the National Health Accounts of the Centers for Medicare & Medicaid Services. The NMES data were released in public use data sets projected to the years 1996 and 2005. This report describes the categories of expenditures and payment sources in the projected data, the population and expenditure reweighting procedures, and alignment of the 1987 NMES to the 1987 National Health Accounts.

Authors: Moeller J, Stagnitti M, Horan E, et al
Title: Outpatient prescription drugs: Data collection and editing in the 1996 Medical Expenditure Panel Survey (HC-010A)
Publication: MEPS Methodology Report No. 12. AHRQ Pub. No. 01-0002. Available on the MEPS Web site
Date: 2001
Abstract: MEPS is the third in a series of nationally representative surveys of medical care use and expenditures sponsored by AHRQ. For the first time in a national expenditure survey, the 1996 MEPS included a detailed collection of information on prescription medicines obtained from pharmacy providers frequented by household sampled persons. The information was collected by means of a linked survey of pharmacy providers. This report describes the procedures adopted to collect and edit these prescription drug data for public release. It includes efforts made to retrieve complete and/or partially missing pharmacy data, the editing techniques used to fill in remaining missing data in the pharmacy database, and the matching/imputation procedure that linked every prescription drug mentioned by the respondent in the MEPS Household Component to a specific prescription drug from the Pharmacy Component (part of the Medical Provider Component).

Authors: Miller GE, Moeller J
Title: Outpatient prescription drug prices and insurance coverage: An analysis by therapeutic drug class and user characteristics from the 1996 Medical Expenditure Panel Survey
Publication: Investing in Health: The Social and Economic Benefits of Health Care Innovation 14:23-57
Date: 2001
Abstract: The authors used a data set that contains information on a nationally representative sample of drug purchases in 1996 to investigate the relationship between the type of insurance individuals have for prescription drugs—private insurance, Medicaid, or uninsured—and both the type of drugs they purchase and the prices they pay for drugs. The authors found that uninsured persons use more generic drugs than privately insured persons but fewer generic drugs than Medicaid recipients. To compare retail drug prices across insurance types, the authors used standardized prices—the retail unit price of each drug relative to a benchmark price. We find that uninsured individuals pay standardized prices that are, on average, 16.5 percent higher than the standardized prices paid by privately insured persons, and 8.4 percent higher than the standardized prices paid by Medicaid recipients.

Authors: Manski R, Moeller J, Maas W
Title: Dental services: An analysis of utilization over 20 years
Publication: J Am Dent Assoc 132:655-64. AHRQ Pub. No. 01-R068
Date: 2001
Abstract: Available on PubMed®

Authors: Manski R, Edelstein B, Moeller J
Title: The impact of insurance coverage on children's dental visits and expenditures, 1996
Publication: J Am Dent Assoc 132:1137-45. AHRQ Pub. No. 01-R083
Date: 2001
Abstract: Available on PubMed®

Authors: Selden T, Moeller J
Title: Estimates of the tax subsidy for employment-related health insurance
Publication: National Tax Journal 53(4)Part 1:877-87
Date: 2000
Abstract: This paper uses the MEDical expenditure microSIMulation model (MEDSIM) health care microsimulation model developed by researchers at AHRQ to compute the magnitude and distribution of the tax subsidy for employment-related health insurance premiums. The authors also presented estimates of the revenue gain that would be associated with a variety of caps on the amount of contributions that can be excluded from the tax base.

Authors: Manski R, Davidson W, Moeller J
Title: Orthodontic dental visits during 1987 and 1996
Publication: Am J Orthodontics Dentofacial Orthopedics 118(1):10-13
Date: 2000
Abstract: Americans underwent approximately 355 million dental procedures during 1987, approximately 8 percent for orthodontic treatment. Individual rates of utilization vary and are not uniform across the population. This article provides estimates of orthodontic utilization for each of several socioeconomic and demographic categories, using household data from the 1987 National Medical Expenditure Survey (NMES) and the 1996 MEPS. These data show that slightly more than 3 percent of the population, or approximately 39 million Americans, visited a dentist to receive orthodontic care nationwide during 1987 and 1996. For those with an orthodontic visit, the mean number of visits per patient decreased in number from 1987 to 1996.

Authors: Huttin C, Moeller J, Stafford R
Title: Patterns and costs for hypertension treatment in the United States
Publication: Clin Drug Invest 20(3):181-95
Date: 2000
Abstract: The objective of this article was to estimate the impact of clinical and nonclinical predictors of patterns of medication use and expenditures for the treatment of hypertension in the United States. Pharmacological treatment was identified through patient self-reports of antihypertensive medications. The results showed that women and the elderly were more likely to obtain medications and had greater expenditures on antihypertensive medications. Insurance had a more striking effect on access to antihypertensive drug therapy than on patterns of drug use or expenditures. Race/ethnicity and patient attitudes toward risk were important determinants of access to antihypertensive drug therapies, as well as patterns of drug use and expenditures.

Authors: Edelstein B, Manski R, Moeller J
Title: Pediatric dental visits during 1996: An analysis of the federal Medical Expenditure Panel Survey
Publication: Pediatr Dent 22(1):17-20. AHRQ Pub. No. 00-R024
Date: 2000
Abstract: Available on PubMed®

Authors: Zabinski D, Selden T, Moeller J, Banthin J
Title: Medical savings accounts: Microsimulation results from a model with adverse selection
Publication: J Health Econ 18:195-218. AHRQ Pub. No. 99-R047
Date: 1999
Abstract: Available on PubMed®

Authors: Manski R, Moeller J, Maas W
Title: Dental services: Use, expenditures and sources of payment, 1987
Publication: J Am Dent Assoc 130:500-8
Date: 1999
Abstract: Available on PubMed®

Authors: Manski R, Moeller J, Maas W
Title: A comparison of dental care expenditures and office-based medical expenditures, 1987
Publication: J Am Dent Assoc 130:659-66
Date: 1999
Abstract: Available on PubMed®

Authors: Moeller J, Banthin J, et al
Title: MEDical Expenditure MicroSIMulation Model (MEDSIM): A brief overview of the model and database
Publication: AHCPR Pub. No. 97-R019
Date: 1996
Abstract: MEDSIM was developed by CFACT. This paper offers a general introduction to the model, its database, and its research and policy applications.

---

 Previous Section       CFACT Author Index       Next Section 

---